High expression levels of the ETS-related gene, ERG, predict adverse outcome and improve molecular risk-based classification of cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B Study.

High expression levels of the ETS-related gene, ERG, predict adverse outcome and improve molecular risk-based classification of cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B Study. J Clin Oncol. 2007 Aug 01; 25(22):3337-43.

View in: PubMed

subject areas

Adult
Antineoplastic Combined Chemotherapy Protocols
Biomarkers, Tumor
DNA-Binding Proteins
Female
Gene Expression Profiling
Gene Expression Regulation, Neoplastic
Humans
Leukemia, Myeloid, Acute
Male
Middle Aged
Predictive Value of Tests
Prognosis
Proportional Hazards Models
Reverse Transcriptase Polymerase Chain Reaction
Risk Assessment
Statistics, Nonparametric
Stem Cell Transplantation
Survival Analysis
Trans-Activators
Transcriptional Regulator ERG
Up-Regulation

authors with profiles

Richard A. Larson